RNA logo

Avidity Biosciences (RNA)

Profile

Full Name

Avidity Biosciences, Inc.

Ticker Symbol

RNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 12, 2020

Indexes

Not included

Website

http://www.aviditybiosciences.com

Employees

391

Key Details

Price

$26.66(+3.49%)

Market cap

$3.20B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.90M(+13.99% YoY)

Annual EPS

-$2.89(+0.69% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$26.66
RNA price is $26.66

30-Day Relative Volume

0.88
RNA 30-day relative volume is 0.88

Price Performance

Price Most recent change

+3.49%
RNA price was up +3.49% on Apr 17, 2025

Price YTD change

-8.32%
RNA price is down -8.32% since January 1st

Price 1-year change

+13.21%
RNA price is up +13.21% year-on-year

Price 3-year change

+46.32%
RNA price is up +46.32% over the past 3 years

Price Range

Price All-time high

$56.00
RNA price is currently -52.39% below its historical high of $56.00

Price 3-year low

$4.83
RNA price is currently +452.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.20B
RNA market capitalization is $3.20 billion

Market cap 3-year change

+256.93%
RNA market capitalization is up +256.93% over the past 3 years

Market cap All-time high

$6.27B
RNA market capitalization is currently -48.89% below its historical high of $6.27 billion

Market cap sector rank

87.24%
RNA market capitalization is higher than 87.24% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+25.75%
RNA shares outstanding is up +25.75% year-on-year

Shares Outstanding 3-Year Change

+143.93%
RNA shares outstanding is up +143.93% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.26
RNA beta is 1.26

200-day SMA

$38.10
RNA price is currently -30.03% below its 200-day simple moving average

50-day SMA

$30.11
RNA price is currently -11.45% below its 50-day simple moving average

RSI

45.20
RNA 14-day relative strength index is 45.20

Volume

0.88
RNA 30-day relative volume is 0.88

ATR

$2.11
RNA average true range is $2.11

10-day Historical Volatility

71.07%
RNA 10-day historical volatility is 71.07%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$10.90M
RNA annual revenue is $10.90 million

Revenue Analysts estimate

$8.35M
RNA annual revenue is currently +30.57% higher than the consensus analysts' forecast

Revenue 1-year change

+13.99%
RNA annual revenue is up +13.99% year-on-year

Revenue Sector rank

29.26%
RNA annual revenue is higher than 29.26% of companies in Healthcare sector

EPS

EPS

-$2.89
RNA annual earnings per share is -$2.89

EPS Analysts estimate

-$3.82
RNA annual earnings per share is currently -24.38% lower than the consensus analysts' forecast

EPS 1-year change

+0.69%
RNA annual earnings per share is up +0.69% year-on-year

EPS Sector rank

30.74%
RNA annual earnings per share is higher than 30.74% of companies in Healthcare sector

Profit

Gross profit

-
RNA annual gross profit value is unknown

Gross margin

-
RNA annual gross profit margin value is unknown

Operating profit

-$378.94M
RNA annual operating income is -$378.94 million

Operating margin

-3477.43%
RNA annual operating profit margin is -3477.43%

Net income

-$322.30M
RNA annual net profit is -$322.30 million

Net margin

-2957.71%
RNA annual net profit margin is -2957.71%

Expenses

Total expenses

$389.83M
RNA annual total expenses is $389.83 million

Operating expenses

$389.83M
RNA annual total operating expenses is $389.83 million

Cost of goods sold

-
RNA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$86.24M
RNA annual SGA is $86.24 million

Depreciation and amortization

$2.78M
RNA annual depreciation & amortization is $2.78 million

Interest expense

-
RNA annual interest expense value is unknown

Income tax

-
RNA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$378.94M
RNA annual earnings before interest & taxes is -$378.94 million

EBITDA

-$376.16M
RNA annual EBITDA is -$376.16 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.56B
RNA annual total assets is $1.56 billion

Non current assets

$21.61M
RNA annual long term assets is $21.61 million

Current assets

$1.54B
RNA annual total current assets is $1.54 billion

Cash and cash equivalents

$219.87M
RNA annual cash & cash equivalents is $219.87 million

Accounts receivable

$0.00
RNA annual accounts receivable is $0.00

Inventory

-
RNA annual inventory value is unknown

Liabilities

Total liabilities

$138.94M
RNA annual total liabilities is $138.94 million

Long term liabilities

$40.92M
RNA annual total long term liabilities is $40.92 million

Current liabilities

$98.02M
RNA annual total current liabilities is $98.02 million

Accounts payable

$8.46M
RNA annual accounts payable is $8.46 million

Debt

Total debt

$6.80M
RNA annual total debt is $6.80 million

Total debt 1-year change

-30.97%
RNA annual total debt is down -30.97% year-on-year

Long term debt

$2.96M
RNA annual long term debt is $2.96 million

Short term debt

$3.84M
RNA annual short term debt is $3.84 million

Equity & Capital

Shareholders equity

$1.42B
RNA annual stockholders equity is $1.42 billion

Book value

$1.42B
RNA annual book value is $1.42 billion

Retained earnings

-$893.07M
RNA annual retained earnings is -$893.07 million

Working capital

$1.44B
RNA annual working capital is $1.44 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$300.87M
RNA annual cash flow from operations is -$300.87 million

Cash from operations 1-year change

-152.7%
RNA annual cash flow from operations is down -152.7% year-on-year

Cash from investing

-$854.20M
RNA annual cash flow from investing activities is -$854.20 million

Cash from investing 1-year change

-556.72%
RNA annual cash flow from investing activities is down -556.72% year-on-year

Cash from financing

$1.19B
RNA annual cash flow from financing activities is $1.19 billion

Cash from financing 1-year change

+1170.3%
RNA annual cash flow from financing activities is up +1170.3% year-on-year

CAPEX

CAPEX

$7.07M
RNA annual capital expenditures is $7.07 million

CAPEX 1-year change

+67.12%
RNA annual capital expenditures is up +67.12% year-on-year

Free Cash Flow

Free cash flow

-$307.94M
RNA annual free cash flow is -$307.94 million

Free cash flow 1-year change

-149.76%
RNA annual free cash flow is down -149.76% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
RNA annual gross profit margin value is unknown

Operating margin

-3477.43%
RNA annual operating profit margin is -3477.43%

Net margin

-2957.71%
RNA annual net profit margin is -2957.71%

ROA & ROE

ROA

-29.40%
RNA annual return on assets is -29.40%

ROE

-33.47%
RNA annual return on equity is -33.47%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RNA price to earnings ratio value is unknown

PE ratio Sector rank

-
RNA price to earnings ratio is unknown

PB Ratio

PB ratio

2.25
RNA price to book ratio is 2.25

PB ratio Sector rank

65.95%
RNA price to book ratio is higher than 65.95% of companies in Healthcare sector

PS Ratio

PS ratio

294.10
RNA price to sales ratio is 294.10

PS ratio Sector rank

97.05%
RNA price to sales ratio is higher than 97.05% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.99B
RNA enterprise value is $2.99 billion

Enterprise value Sector rank

85.29%
RNA enterprise value is higher than 85.29% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.95
RNA EV/EBITDA is -7.95

EV/EBITDA Sector rank

13.23%
RNA EV/EBITDA is higher than 13.23% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

15.73
RNA annual current ratio is 15.73

Quick ratio

-
RNA annual quick ratio value is unknown

Leverage

Debt to equity

0.00
RNA annual debt to equity ratio is 0.00

Interest coverage ratio

-
RNA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
RNA piotroski f-score value is unknown

Altman Z-Score

13.36
RNA altman z-score is 13.36

Analyst ratings

Recent major analysts updates

Apr 9, 25 Needham
Buy
Mar 18, 25 HC Wainwright & Co.
Buy
Mar 17, 25 Needham
Buy
Mar 17, 25 HC Wainwright & Co.
Buy
Mar 17, 25 Chardan Capital
Buy
Mar 13, 25 Citigroup
Buy
Mar 12, 25 BMO Capital
Outperform
Mar 10, 25 B of A Securities
Buy
Mar 7, 25 Scotiabank
Sector Outperform
Feb 28, 25 Chardan Capital
Buy

Institutional Ownership

Similar stocks

SLNO logo
Soleno Therapeutics (SLNO)
IRTC logo
iRhythm Technologies (IRTC)
CRSP logo
CRISPR Therapeutics AG (CRSP)
ZLAB logo
Zai Lab Limited (ZLAB)
RARE logo
Ultragenyx Pharmaceutical (RARE)
OSCR logo
Oscar Health (OSCR)
AMED logo
Amedisys (AMED)
ICUI logo
ICU Medical (ICUI)
ACLX logo
Arcellx (ACLX)
  • What is the ticker symbol for Avidity Biosciences?
  • Does Avidity Biosciences pay dividends?
  • What sector is Avidity Biosciences in?
  • What industry is Avidity Biosciences in?
  • What country is Avidity Biosciences based in?
  • When did Avidity Biosciences go public?
  • Is Avidity Biosciences in the S&P 500?
  • Is Avidity Biosciences in the NASDAQ 100?
  • Is Avidity Biosciences in the Dow Jones?
  • When was Avidity Biosciences's last earnings report?
  • When does Avidity Biosciences report earnings?
  • Should I buy Avidity Biosciences stock now?

What is the ticker symbol for Avidity Biosciences?

The ticker symbol for Avidity Biosciences is NASDAQ:RNA

Does Avidity Biosciences pay dividends?

No, Avidity Biosciences does not pay dividends

What sector is Avidity Biosciences in?

Avidity Biosciences is in the Healthcare sector

What industry is Avidity Biosciences in?

Avidity Biosciences is in the Biotechnology industry

What country is Avidity Biosciences based in?

Avidity Biosciences is headquartered in United States

When did Avidity Biosciences go public?

Avidity Biosciences's initial public offering (IPO) was on June 12, 2020

Is Avidity Biosciences in the S&P 500?

No, Avidity Biosciences is not included in the S&P 500 index

Is Avidity Biosciences in the NASDAQ 100?

No, Avidity Biosciences is not included in the NASDAQ 100 index

Is Avidity Biosciences in the Dow Jones?

No, Avidity Biosciences is not included in the Dow Jones index

When was Avidity Biosciences's last earnings report?

Avidity Biosciences's most recent earnings report was on Feb 27, 2025

When does Avidity Biosciences report earnings?

The next expected earnings date for Avidity Biosciences is May 9, 2025

Should I buy Avidity Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page